SG30287G - 2-phenoxyalkyl-1,2,4-triazol-3-one anti-depressants - Google Patents

2-phenoxyalkyl-1,2,4-triazol-3-one anti-depressants

Info

Publication number
SG30287G
SG30287G SG302/87A SG30287A SG30287G SG 30287 G SG30287 G SG 30287G SG 302/87 A SG302/87 A SG 302/87A SG 30287 A SG30287 A SG 30287A SG 30287 G SG30287 G SG 30287G
Authority
SG
Singapore
Prior art keywords
phenoxyalkyl
depressants
triazol
Prior art date
Application number
SG302/87A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG30287(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SG30287G publication Critical patent/SG30287G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG302/87A 1981-03-16 1987-03-27 2-phenoxyalkyl-1,2,4-triazol-3-one anti-depressants SG30287G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Publications (1)

Publication Number Publication Date
SG30287G true SG30287G (en) 1987-07-17

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
SG302/87A SG30287G (en) 1981-03-16 1987-03-27 2-phenoxyalkyl-1,2,4-triazol-3-one anti-depressants

Country Status (26)

Country Link
US (1) US4338317A (it)
JP (1) JPS57159774A (it)
KR (1) KR880001374B1 (it)
AT (1) AT384022B (it)
BE (1) BE892503A (it)
CA (1) CA1198436A (it)
CH (1) CH649539A5 (it)
CY (1) CY1373A (it)
DE (1) DE3209557A1 (it)
DK (1) DK158728C (it)
ES (1) ES510449A0 (it)
FI (1) FI73670C (it)
FR (1) FR2501690B1 (it)
GB (1) GB2096137B (it)
GR (1) GR76076B (it)
HK (1) HK4788A (it)
IE (1) IE52788B1 (it)
IT (1) IT1148137B (it)
KE (1) KE3711A (it)
LU (1) LU84011A1 (it)
MX (1) MX9203176A (it)
NL (2) NL190757C (it)
SE (1) SE447256B (it)
SG (1) SG30287G (it)
YU (1) YU43256B (it)
ZA (1) ZA821359B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0769297A1 (en) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Use of nefazodone for the manufacture of a medicament for the treatment of panic attack
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
AU2452397A (en) * 1996-07-31 1998-02-20 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
EP1189616A2 (en) * 1999-04-09 2002-03-27 Sepracor Inc. S-hydroxynefazodone
CA2369732A1 (en) 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
CA2356450C (en) 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
AU2003232805A1 (en) * 2002-05-24 2003-12-12 Carl-Fr. Coester Pharmaceutical active substance combination and the use thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
BRPI0409685A (pt) * 2003-04-30 2006-04-18 Fmc Corp derivados cìclicos fenil-substituìdos
JP4864719B2 (ja) * 2003-11-26 2012-02-01 ファイザー・プロダクツ・インク Ｇｓｋ−３インヒビターとしてのアミノピラゾール誘導体
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
AR049382A1 (es) * 2004-05-18 2006-07-26 Fmc Corp Derivados de la urea ciclica substituida
WO2007008758A2 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
EP2183227B1 (en) * 2007-08-07 2014-09-24 Prosarix Limited 1,2,4-triazole derivatives as serotonergic modulators
US9339500B2 (en) 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
ES8305756A1 (es) 1983-04-16
SE447256B (sv) 1986-11-03
AU8117082A (en) 1982-09-23
AT384022B (de) 1987-09-25
US4338317A (en) 1982-07-06
FR2501690B1 (fr) 1985-07-05
IE52788B1 (en) 1988-03-02
CY1373A (en) 1987-08-07
DE3209557C2 (it) 1993-07-15
HK4788A (en) 1988-01-29
FR2501690A1 (fr) 1982-09-17
DK158728C (da) 1990-12-03
YU52582A (en) 1985-06-30
LU84011A1 (fr) 1983-02-22
IE820589L (en) 1982-09-16
CA1198436A (en) 1985-12-24
JPS57159774A (en) 1982-10-01
NL8201021A (nl) 1982-10-18
FI73670C (fi) 1987-11-09
GB2096137B (en) 1985-01-03
NL190757B (nl) 1994-03-01
ZA821359B (en) 1983-01-26
KE3711A (en) 1987-04-30
AU555888B2 (en) 1986-10-16
JPH0237353B2 (it) 1990-08-23
DK112582A (da) 1982-09-17
ES510449A0 (es) 1983-04-16
KR830009089A (ko) 1983-12-17
SE8201631L (sv) 1982-09-17
IT1148137B (it) 1986-11-26
DE3209557A1 (de) 1982-12-09
GB2096137A (en) 1982-10-13
FI820856L (fi) 1982-09-17
IT8247978A0 (it) 1982-03-12
ATA104582A (de) 1987-02-15
NL970014I1 (nl) 1997-06-02
NL970014I2 (nl) 1997-09-01
KR880001374B1 (ko) 1988-07-29
BE892503A (fr) 1982-09-15
NL190757C (nl) 1994-08-01
FI73670B (fi) 1987-07-31
GR76076B (it) 1984-08-03
MX9203176A (es) 1992-07-01
DK158728B (da) 1990-07-09
CH649539A5 (de) 1985-05-31
YU43256B (en) 1989-06-30

Similar Documents

Publication Publication Date Title
SG30287G (en) 2-phenoxyalkyl-1,2,4-triazol-3-one anti-depressants
GB2142631B (en) 1,2,4-triazol-3-one antidepressants
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
GB2073752B (en) 2,6-diaminobularines
GB2106902B (en) 2,2-disubstituted-ethylamines
CS701282A1 (en) Derivaty 2,5 piperazindionu
GB2075012B (en) 4,1-benzoxazepines
GB2135303B (en) 3,5-dinitrophthalimides
PT73240B (en) 2,3-bis-hydroxybenzyl-derivatives
ZW6581A1 (en) 2,5-disubstituted-4-pirimidones
NZ197556A (en) 1,1 -alkylenediiminobis(4-( -aminoalkylamino)-anthraquinones
CS770482A2 (en) Zpusob vyroby 1 (3 benzyloxyfenyl) 1,1 dimethylheptanu
JPS57116050A (en) 2,4-diamino-5-benzylpyrimidine
GB2125788B (en) 17,18-dehydro-apovincaminol
GB2102429B (en) 9-hydroxy-3-oxo-4,17(20)-pregnadiene-20-carboxaldehyde
GB2086387B (en) 1,8-dihydroxy-9-anthrones
GB2105330B (en) Pesticidal 5-phenoxyphenyl-tetrahydro-1,3,5-thiadiazin-4-ones
GB2080791B (en) 1,4-benzoxazines
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
ZA81222B (en) 1,3-diformyloxy -2-bromo-2-nitropropane
CS546582A1 (en) Zpusob pripravy farmakologicky ucinnych derivatu 1,4 diaminoantrachinonu
EP0058885A3 (en) Herbicidal 1,2,4-triazin-5-ones
JPS56166193A (en) 1,4;3,6-dianhydro-2,5-diazido-2,5-dideoxy- hexitol
GB2098605B (en) 1,3-dihydro-2h-imidazol-2-ones
GB2106513B (en) Imidazo- and pyrimido-1,3,5-thiadiazin-4-ones